The period of exclusivity protects your brand-name drug from generic competition. But it doesn’t last forever, and loss of exclusivity could mean the end of your product’s value – and revenue stream. You need to strategically prepare for this phase, but where do you start?

During this on-demand fireside chat, experts in global drug pricing and market access strategy from Model N and Global Pricing Innovations (GPI) will provide guidance on how you can mitigate the impact of loss of exclusivity and ensure optimum returns on new drug innovation investment. Our panelists will share the state of the industry, highlight best practices, and discuss strategies to deal with exclusivity. They will also explain how you can use Model N Global Pricing Management to capture loss of exclusivity information, track competitors’ pricing, simulate pricing decisions, and calculate revenue impact.

Topics covered include:

• Effectively prepare for loss-of-exclusivity events
• Simulate pricing to determine the impact of pricing decisions
• Evaluate the initial and five-year impact of a competitor’s entry following loss of exclusivity